Patents Assigned to Billings Pharmaceuticals, Inc.
  • Chiral integrin modulators and methods of use thereof
    Patent number: 7321002
    Abstract: The invention provides enantiomers of ajoene and derivatives of Z(?)-ajoene. The derivative of Z(?)-ajoene are useful for modulating integrin-mediated functions, for treating disorders, diseases or conditions in which integrins play a role, and for treating tissues to improve their condition for a subsequent use, such as transplantation.
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: January 22, 2008
    Assignee: Billings Pharmaceuticals, Inc.
    Inventors: John B. Davidson, Alexander V. Tatarintsev, Ali S. Turgiev, James K. Hildreth
  • Chiral integrin modulators and methods of use thereof
    Patent number: 7045663
    Abstract: The invention provides enantiomers of ajoene and derivtives of Z(?)-ajoene. The derivative of Z(?)-ajoene are useful for modulating integrin-mediated functions, for treating disorders, diseases or conditions in which integrins play a role, and for treating tissues to improve their condition for a subsequent use, such as transplantation.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: May 16, 2006
    Assignee: Billings Pharmaceuticals, Inc.
    Inventors: John B. Davidson, Alexander V. Tatarintsev, Ali S. Turgiev, James K. Hildreth
  • Methods of using integrin modulators for treatment of inflammation
    Patent number: 6177475
    Abstract: The invention provides methods of treating inflammatory diseases and conditions by administering an effective amount of an integrin modulating agent, as further defined and specified herein, to an animal suffering from one of the diseases or conditions. The preferred integrin modulating agents are ajoene and disintegrins, variants and analogs of disintegrins.
    Type: Grant
    Filed: May 12, 1997
    Date of Patent: January 23, 2001
    Assignee: Billings Pharmaceuticals, Inc.
    Inventors: Alexander V. Tatarintsev, Ali S. Turgiev, John B. Davidson